TABLE 2.
Univariate logistic regression |
Multivariate logistic regression |
|
Silica (N = 95)* |
Silica |
|
Variables | OR (95% CI) | Adjusted OR (95% CI) |
Age ≥ 50 years | 0.53 (0.33–0.84) | 0.42 (0.22–0.75) |
Male sex | 6.63 (4.27–10.28) | 7.87 (4.51–13.84) |
Caucasian | 1.15 (0.71–3.51) | – |
Disease duration ≥ 5 years | 0.75 (0.49–1.14) | – |
Treatment with CYC or MMF | 1.95 (1.03–3.45) | 1.11 (0.45–2.48) |
Smoking | 1.69 (1.08–2.69) | 1.05 (0.60–1.89) |
Diffuse disease | 1.96 (1.28–2.99) | 1.49 (0.75–2.94) |
Digital ulcer/pitting scars | 1.28 (0.84–1.94) | – |
Necrosis/gangrene/amputation | 0.94 (0.60–1.44) | – |
Nailfold capillaroscopy | 0.76 (0.48–1.23) | – |
Pulmonary arterial hypertension | 0.93 (0.40–1.92) | – |
Joint impairment | 0.82 (0.49–1.31) | – |
History of renal crisis | 2.15 (0.87–4.60) | – |
Cancer | 1.05 (0.46–2.10) | – |
ACA antibody | 0.60 (0.36–0.97) | 0.91 (0.48–1.66) |
ATA antibody | 1.54 (0.87–2.60) | – |
U1RNP | 1.36 (0.51–3.00) | – |
Ro52 | 0.96 (0.57–1.56) | – |
PDGFR | – | – |
Ku | – | – |
Nor90 | 0.52 (0.03–2.49) | – |
Nucleolar antibodies | 1.09 (0.62–1.83) | – |
ILD | 1.45 (0.93–2.22) | – |
FVC < 70 | 2.20 (1.23–3.74) | 2.08 (1.00–4.27) |
GI_14 | 1.08 (1.02–1.15) | 1.11 (1.01–1.21) |
Rodnan score | 1.03 (1.01–1.04) | 1.00 (0.96–1.03) |
Medsger—General | 1.12 (0.95–1.31) | – |
Medsger—Peripheral Vascular | 1.18 (0.97–1.43) | – |
Medsger—Skin | 1.31 (0.99–1.72) | – |
Medsger—Joint/Tendon | 1.19 (0.99–1.41) | – |
Medsger—Muscle | 1.17 (0.90–1.47) | – |
Medsger—GI tract | 1.33 (1.01–1.79) | 0.99 (0.69–1.43) |
Medsger—Lung | 1.24 (1.03–1.48) | 1.08 (0.82–1.42) |
Medsger—Heart | 1.10 (0.89–1.33) | – |
Medsger—Kidney | 1.12 (0.77–1.48) | – |
* Reference group no exposure to silica.
– Defines not available/not applicable.
Bold signifies significant values; Variable definitions as above.